Fresenius SE & Co. (OTCMKTS:FSNUY) Short Interest Up 625.2% in February

Fresenius SE & Co. (OTCMKTS:FSNUY) saw a significant growth in short interest in February. As of February 27th, there was short interest totaling 65,445 shares, a growth of 625.2% from the February 12th total of 9,025 shares. Currently, 0.0% of the company’s stock are sold short. Based on an average daily trading volume, of 79,373 shares, the short-interest ratio is presently 0.8 days. Based on an average daily trading volume, of 79,373 shares, the short-interest ratio is presently 0.8 days. Currently, 0.0% of the company’s stock are sold short.

Wall Street Analysts Forecast Growth

FSNUY has been the topic of a number of recent research reports. Citigroup reiterated a “buy” rating on shares of Fresenius SE & Co. in a research note on Tuesday, February 3rd. Morgan Stanley restated an “overweight” rating on shares of Fresenius SE & Co. in a report on Monday, December 15th. Three equities research analysts have rated the stock with a Buy rating, According to MarketBeat.com, Fresenius SE & Co. currently has a consensus rating of “Buy”.

Fresenius SE & Co. Stock Down 0.9%

Shares of FSNUY traded down $0.12 during midday trading on Wednesday, hitting $13.85. 890 shares of the company’s stock traded hands, compared to its average volume of 67,350. The company has a current ratio of 1.26, a quick ratio of 0.99 and a debt-to-equity ratio of 0.49. The stock has a market capitalization of $31.20 billion, a price-to-earnings ratio of 21.98 and a beta of 0.75. Fresenius SE & Co. has a 1 year low of $9.78 and a 1 year high of $33.93. The firm’s fifty day moving average is $14.56 and its 200-day moving average is $14.45.

Fresenius SE & Co. (OTCMKTS:FSNUY) last announced its earnings results on Wednesday, February 25th. The company reported $0.28 earnings per share (EPS) for the quarter. Fresenius SE & Co. had a return on equity of 10.38% and a net margin of 5.71%.The company had revenue of $6.94 billion for the quarter. As a group, sell-side analysts anticipate that Fresenius SE & Co. will post 0.79 earnings per share for the current year.

About Fresenius SE & Co.

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.